Industry, Mergers and Acquisitions, Vaccines
April 3, 2024
Via: Biopharm InternationalOn Mar. 25, 2024 Univercells announced a collaboration with Altamira Therapeutics, a producer of nanoparticle-based technology, under which Univercells will use Altamira’s SemaPhore nanoparticle platform to deliver messenger RNA (mRNA) vaccines. Also on Mar. 25, Andelyn Biosciences, a contract development […]
Manufacturing, Research and Development
June 22, 2023
Via: Biopharm InternationalOn June 22, 2023, Andelyn Biosciences, a cell and gene therapy (CGT) contract development and manufacturing organization, announced the opening of its newly constructed manufacturing headquarters in Columbus, Ohio. According to a company press release, the 180,000-ft2 facility is intended […]
Cell and Gene Therapy, Industry, Mergers and Acquisitions
February 1, 2023
Via: Contract PharmaAndelyn Biosciences, a gene therapy contract development and manufacturing organization (CDMO), has partnered with Odylia Therapeutics, a nonprofit 501(c)(3) biotech focused on accelerating rare disease drug development, to manufacture a novel gene therapy (OT-004) to treat vision loss caused by […]
July 19, 2024
July 11, 2024
July 11, 2024